EyeGene Inc.

Research EyeGene Inc. (185490.KQ) on Bullrun: market cap KRW 84.33B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker185490.KQ
ExchangeKQ
CountrySouth Korea
SectorHealthcare
IndustryBiotechnology
CurrencyKRW
Market capKRW 84.33B
Financial periodQ2 2026
RevenueKRW 1.34B
Net income-KRW 3.75B
Free cash flow-KRW 3.04B
Gross margin24.4%

Valuation Snapshot

latest market cap is KRW 84.33B.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	KRW 84.33B	n/a	n/a	n/a

Dividend history

About EyeGene Inc.

EyeGene Inc. engages in the research and development of biopharmaceutical drugs for the treatment and prevention of age-related diseases in South Korea. Its product pipeline comprises EG-Mirotin, which has completed Phase 2a clinical trial to treat diabetic retinopathy; EG-Decorin which completed Phase 2 clinical trial for the treatment of pressure ulcers and wound healing; and EG-Myocin, which has completed Phase II clinical trials for the treatment of myocardial ischemia/reperfusion injury.

Related stock research

South Korea stocks South Korea Healthcare stocks A-Z stock index

Other Healthcare stocks

ORIENT BIO Inc. (002630.KS) GC Corp. (005250.KS) Pharmicell Co., Ltd. (005690.KS) Kanaph Therapeutics Inc. (0082N0.KQ) Samik Pharmaceutical Company LTD. (014950.KQ) HLB Co., Ltd. (028300) Mgen Solutions Co., Ltd. (032790.KQ) Daesung Microbiological Labs. Co., Ltd. (036480.KQ) Seoulin Bioscience Co.,Ltd. (038070.KQ) Hyundai Bioscience Co., Ltd. (048410.KQ) iNtRON Biotechnology, Inc. (048530.KQ) Synergy Innovation Co., Ltd. (048870.KQ)

Frequently asked questions

What is EyeGene Inc.'s market cap?

EyeGene Inc.'s market capitalization is KRW 84.33B.